Cell line · CVCL_0397
LS180
Cancer cell line, Homo sapiens. Colon adenocarcinoma. 54 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. LS180. Cell lines, record CVCL_0397. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0397
On this page
Cell line
As Cellosaurus gives it.
- Name
- LS180
- Accession
- CVCL_0397
- RRID
- RRID:CVCL_0397
- Synonyms
- LS-180, LS 180, Laboratory of Surgery 180
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 58Y
- Category
- Cancer cell line
- Diseases
- Colon adenocarcinoma (NCIt C4349)
- Derived from
- Colon (in situ)
- Cell type
- Epithelial cell of colon
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers54
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Dihydroartemisinin inhibits mutant KRAS to potentiate regorafenib plus anti-PD-1 in KRAS-mutant colorectal cancer liver metastases. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Visceral and subcutaneous adipose stem cells modulate colorectal cancer cell progression: direct and indirect contact distinctly accelerate tumor aggressiveness. | Mol Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Microsatellite Instable Cancer Cells Acquire On-target Resistance Mutations to WRN Helicase Inhibitors. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ROME, an Ancient Gene with a Novel Function in Vertebrates, Is a Key Modulator of Embryonal Development and Cancer Metastasis. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRASG12D Inhibitor. | Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting WEE1 in ARID1A/TP53 Concurrent Mutant Colorectal Cancer by Exploiting R-Loop Accumulation and DNA Repair Deficiencies. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Defining the Antitumor Mechanism of Action of a Clinical-stage Compound as a Selective Degrader of the Nuclear Pore Complex. | Cancer Discov | 2025 | Its Methods give the RRID and name the line | PubMed | |
| GALNT7 Stratifies dMMR/MSI Colorectal Cancer into Distinct Molecular Subsets Associated with Prognosis and PD-L1 Expression. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| BMP antagonist CHRDL2 enhances the cancer stem-cell phenotype and increases chemotherapy resistance in colorectal cancer. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The solute carrier superfamily interactome. | Mol Syst Biol | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 54
See all 54 papersRelatives60
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | CellSensor CYP1A1-bla LS-180 | CVCL_KS51 | Cell lines | |
| Derived from it | LS174T | CVCL_1384 | Cell lines | |
| Derived from it | LS180-MFSD3-KO-c4 | CVCL_D4V2 | Cell lines | |
| Derived from it | LS180-MFSD3-KO-c6 | CVCL_D4V3 | Cell lines | |
| Derived from it | LS180-NIPAL1-KO-c11 | CVCL_D4V4 | Cell lines | |
| Derived from it | LS180-NIPAL1-KO-c3 | CVCL_D4V5 | Cell lines | |
| Derived from it | LS180-SLC10A6-KO-c3 | CVCL_D4V6 | Cell lines | |
| Derived from it | LS180-SLC10A6-KO-c8 | CVCL_D4V7 | Cell lines | |
| Derived from it | LS180-SLC12A2-KO-c11 | CVCL_D4V8 | Cell lines | |
| Derived from it | LS180-SLC12A2-KO-c9 | CVCL_D4V9 | Cell lines |
1 to 10 of 60
See all 60 relativesCell banks10
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CCL-187 | Discontinued | Cellosaurus |
| ATCC | CL-187 | ATCC | |
| AddexBio | C0009006/56 | Cellosaurus | |
| BCRC | 60100 | BCRC | |
| CLS | 305823 | CLS | |
| ECACC | 87021202 | ECACC | |
| EDITGENE | EDC00373 | EDITGENE | |
| ICLC | HTL01016 | ICLC | |
| IZSLER | BS TCL 82 | Cellosaurus | |
| NCBI_Iran | C508 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0397
GET https://conductscience.org/api/cell-lines/v1/CVCL_0397/papers?page=2